Kobayashi Kunihiko 小林国彦

… Alternative Names

小林国彦コバヤシクニヒコ

KOBAYASHI Kunihiko 小林国彦

Less

Researcher Number	30205455
Other IDs
Affiliation (Current)	2025: 埼玉医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2016 – 2023: 埼玉医科大学, 医学部, 教授 2006: 国立保健医療科学院, 助教授 2005 – 2006: 埼玉医科大学, 第2内科学, 助教授 1988: 日本医科大学, 医学部, 助手
Review Section/Research Field	Except Principal Investigator Respiratory organ internal medicine / Basic Section 52010:General internal medicine-related / Public health/Health science
Keywords	Except Principal Investigator QOL / 放射線治療 / 乳がん / HRQOL20 / EORTC QLQ-C30 / 肺癌 / 抗癌剤 / がん患者 / アドヒアランス / CD4T細胞 … More / 抗PD-1抗体 / T細胞免疫モニタリング / 制御性T細胞 / CD4 T細胞エフェクター / CD62LlowCD4 T細胞 / CD62Llow CD4 T細胞 / 末梢血T細胞クラスター / 免疫チェックポイント阻害薬治療 / Treg / CD62L / 末梢血バイオマーカー / CD4 T細胞 / PD-1 / 免疫チェックポイント阻害薬 / 免疫学 / 癌 / T細胞免疫 / 抗がん剤治療 / エフェクターT細胞 / 腫瘍免疫 / 免疫チェックポイント / PFS / 末梢血単核球 / 小細胞肺癌 / 生活の質（ＱＯＬ） / 化学療法 / 肺がん / applicability / evaluation / multicultural / equivalence / Scoring method / 文化差 / アウトカム指標 / 適用可能性 / 評価 / 多文化 / 同等性 / スコア変換 / corticosteroid / 養子免疫療法 / Lymphokine activated killer(LAK)cell Less

長期治療をともなう乳がん患者の治療アドヒアランスに及ぼす要因と治療継続への影響
- Principal Investigator
  
  松田彩子
- Project Period (FY)
  2019 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  National Institute of Public Health
  Teikyo University
Study on a type of chemotherapy regimen that induces immune status into response pattern for anti-PD-1 antibody in small lung cancer patients
- Principal Investigator
  
  Nishihara Fuyumi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Saitama Medical University
Development of Breakthrough Immune Checkpoint Inhibitory Therapy Using Novel Immunological Biomarkers
- Principal Investigator
  
  KAGAMU HIROSHI
- Project Period (FY)
  2017 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Saitama Medical University
Study of the QOL monitoring of the cancer patient
- Principal Investigator
  
  Kubota Kaoru
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Nippon Medical School
Outcome evaluation in health science : Cross-cultural equivalence in the quality of life scoring procedure
- Principal Investigator
  
  YAMAOKA Kazue
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Public health/Health science
- Research Institution
  The National Institute of Public Health
延命効果向上を目指した化学療法と養子免疫療法の適切な併用条件の確立に関する研究
- Principal Investigator
  
  仁井谷久暢
- Project Period (FY)
  1988
- Research Category
  
  Grant-in-Aid for Cancer Research
- Research Institution
  Nippon Medical School

All 2021 2020 2019 2018 2017

All Journal Article Presentation

[Journal Article] Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.2021
- Author(s)
  Mouri, A., K. Kaira, O. Yamaguchi, K. Hashimoto, Y. Miura, A. Shiono, S. Shinomiya, T. Akagami, H. Imai, K. Kobayashi, and H. Kagamu.
- Journal Title
  
  Front Oncol.
  
  Volume: 11 Pages: 610952-610952
- DOI
  10.3389/fonc.2021.610952
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04184
[Journal Article] Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.2021
- Author(s)
  Imai, H., T. Kishikawa, H. Minemura, Y. Yamada, T. Ibe, O. Yamaguchi, A. Mouri, Y. Hamamoto, K. Kanazawa, T. Kasai, K. Kaira, T. Kaburagi, K. Minato, K. Kobayashi, and H. Kagamu.
- Journal Title
  
  Cancer Med.
  
  Volume: 10 Issue: 20 Pages: 6971-6984
- DOI
  10.1002/cam4.4220
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04184
[Journal Article] Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.2021
- Author(s)
  Imai, H., T. Kishikawa, H. Minemura, Y. Yamada, T. Ibe, K. Mori, O. Yamaguchi, A. Mouri, Y. Hamamoto, K. Kanazawa, T. Kasai, K. Kaira, T. Kaburagi, K. Minato, K. Kobayashi, and H. Kagamu.
- Journal Title
  
  Oncology.
  
  Volume: 99 Issue: 9 Pages: 562-570
- DOI
  10.1159/000516745
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04184
[Journal Article] Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs.2021
- Author(s)
  Mouri, A., K. Kaira, O. Yamaguchi, K. Hashimoto, Y. Miura, A. Shiono, S. Shinomiya, H. Imai, K. Kobayashi, and H. Kagamu.
- Journal Title
  
  J Clin Med.
  
  Volume: 10 Issue: 16 Pages: 3744-3744
- DOI
  10.3390/jcm10163744
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04184
[Journal Article] CD4(+) T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy.2020
- Author(s)
  Kagamu H, Kitano S, Yamaguchi O, Yoshimura K, Horimoto K, Kitazawa M, et al.
- Journal Title
  
  Cancer Immunol Res
  
  Volume: 8 Issue: 3 Pages: 334-344
- DOI
  10.1158/2326-6066.cir-19-0574
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04184, KAKENHI-PROJECT-17K09665
[Journal Article] D4(+) T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy.2020
- Author(s)
  Kagamu, H., Kitano, S., Yamaguchi, O., Yoshimura, K., Horimoto, K., Kitazawa, M., Fukui, K., Shiono, A., Mouri, A., Nishihara, F., Miura, Y., Hashimoto, K., Murayama, Y., Kaira, K., and Kobayashi, K.
- Journal Title
  
  Cancer Immunol Res
  
  Volume: 8 Pages: 334-344
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04184
[Journal Article] Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events2020
- Author(s)
  Miura Yu、Mouri Atsuto、Kaira Kyoichi、Yamaguchi Ou、Shiono Ayako、Hashimoto Kosuke、Nishihara Fuyumi、Shinomiya Shun、Akagami Tomoe、Murayama Yoshitake、Abe Takanori、Noda Shin‐ei、Kato Shingo、Kobayashi Kunihiko、Kagamu Hiroshi
- Journal Title
  
  Thoracic Cancer
  
  Volume: 11 Issue: 5 Pages: 1280-1287
- DOI
  10.1111/1759-7714.13394
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09665, KAKENHI-PROJECT-17H04184
[Journal Article] Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab2019
- Author(s)
  Yamaguchi Ou、Kaira Kyoichi、Hashimoto Kosuke、Mouri Atsuto、Miura Yu、Shiono Ayako、Nishihara Fuyumi、Murayama Yoshitake、Noda Shin‐ei、Kato Shingo、Kobayashi Kunihiko、Kagamu Hiroshi
- Journal Title
  
  Thoracic Cancer
  
  Volume: 10 Issue: 4 Pages: 992-1000
- DOI
  10.1111/1759-7714.13044
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04184, KAKENHI-PROJECT-17K16058, KAKENHI-PROJECT-17K09665
[Journal Article] Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer2019
- Author(s)
  Uchida Takahiro、Kaira Kyoichi、Yamaguchi Ou、Mouri Atsuto、Shiono Ayako、Miura Yu、Hashimoto Kosuke、Nishihara Fuyumi、Murayama Yoshitake、Kobayashi Kunihiko、Kagamu Hiroshi
- Journal Title
  
  Thoracic Cancer
  
  Volume: 10 Issue: 4 Pages: 975-979
- DOI
  10.1111/1759-7714.13039
- Data Source
  KAKENHI-PROJECT-17H04184
[Journal Article] Combination Therapy with Carboplatin and Paclitaxel for Small Cell Lung Cancer2019
- Author(s)
  Atsuto Mouri, Ou Yamaguchi, Sachiko Miyauchi, Ayako Shiono, Harue Utsugi, Fuyumi Nishihara, Yoshitake Murayama, Hiroshi Kagamu, Kunihiko Kobayashi
- Journal Title
  
  Respiratory investigation
  
  Volume: 57 Issue: 1 Pages: 34-39
- DOI
  10.1016/j.resinv.2018.09.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16058, KAKENHI-PROJECT-17K09665
[Journal Article] Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients2019
- Author(s)
  Shiono Ayako、Kaira Kyoichi、Mouri Atsuto、Yamaguchi Ou、Hashimoto Kosuke、Uchida Takahiro、Miura Yu、Nishihara Fuyumi、Murayama Yoshitake、Kobayashi Kunihiko、Kagamu Hiroshi
- Journal Title
  
  Thoracic Cancer
  
  Volume: 10 Issue: 4 Pages: 775-781
- DOI
  10.1111/1759-7714.12998
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04184, KAKENHI-PROJECT-17K16058, KAKENHI-PROJECT-17K09665
[Journal Article] Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer2019
- Author(s)
  Mouri Atsuto、Kaira Kyoichi、Yamaguchi Ou、Shiono Ayako、Miura Yu、Hashimoto Kosuke、Nishihara Fuyumi、Murayama Yoshitake、Kobayashi Kunihiko、Kagamu Hiroshi
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 84 Issue: 4 Pages: 873-880
- DOI
  10.1007/s00280-019-03926-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09665
[Journal Article] Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations.2018
- Author(s)
  Oizumi S, Sugawara S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Watanabe S, Ito K, Gemma A, Demura Y, Fukumoto S, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Aiba K, Nukiwa T.
- Journal Title
  
  ESMO Open
  
  Volume: 3(2) Issue: 2 Pages: e000313-e000313
- DOI
  10.1136/esmoopen-2017-000313
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09562, KAKENHI-PROJECT-17K09639, KAKENHI-PROJECT-15K09164, KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K09237
[Journal Article] Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma2018
- Author(s)
  Ko R, Shukuya T, Okuma Y, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Fujiwara A, Sugiyama T, Azuma K, Muraki K, Yamasaki M, Tanaka H, Takashima Y, Soda S, Ishimoto O, Koyama N, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan Study Group.
- Journal Title
  
  Oncologist
  
  Volume: unknown Issue: 10 Pages: 1210-1217
- DOI
  10.1634/theoncologist.2017-0586
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09562, KAKENHI-PROJECT-17K09671, KAKENHI-PROJECT-18K08185, KAKENHI-PROJECT-15K09230
[Journal Article] Pulmonary Tumor Embolism Due to Squamous Cell Carcinoma of the Uterine Cervix2018
- Author(s)
  Okazaki S, Abe T, Takayanagi N, Yasuda M, Sakai F, Kobayashi K, Kato S.
- Journal Title
  
  A Case Report. In Vivo
  
  Volume: 32(2) Pages: 337-343
- Data Source
  KAKENHI-PROJECT-16K09562
[Journal Article] Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan2017
- Author(s)
  Fischer M. J.、Inoue K.、Matsuda A.、Kroep J. R.、Nagai S.、Tozuka K.、Momiyama M.、Weijl N. I.、Langemeijer-Bosman D.、Ramai S. R. S.、Nortier J. W. R.、Putter H.、Yamaoka K.、Kubota K.、Kobayashi K.、Kaptein A. A.
- Journal Title
  
  Breast Cancer Research and Treatment
  
  Volume: 166 Issue: 2 Pages: 459-471
- DOI
  10.1007/s10549-017-4417-z
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09562
[Journal Article] The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancer2017
- Author(s)
  Vivat B, Young TE, Winstanley J, Arraras JI, Black K, Boyle F, Bredart A, Costantini A, Guo J, Irarrazaval ME, Kobayashi K, Kruizinga R, Navarro M, Omidvari S, Rohde GE, Serpentini S, Spry N, Van Laarhoven HWM, Yang GM; EORTC Quality of Life Group.
- Journal Title
  
  Eur J Cancer Care (Engl)
  
  Volume: 26(6) Issue: 6 Pages: e12697-e12697
- DOI
  10.1111/ecc.12697
- Data Source
  KAKENHI-PROJECT-16K09562
[Journal Article] The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer2017
- Author(s)
  Willem A. van der Kloot, Yuka Uchida, Kenichi Inoue, Kunihiko Kobayashi, Kazue Yamaoka, Hans W. R. Nortier, Ad A. Kaptein
- Journal Title
  
  Chin Clin Oncol
  
  Volume: 5(1) Pages: 3-3
- Data Source
  KAKENHI-PROJECT-16K09562
[Journal Article] A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.2017
- Author(s)
  Inoue Y, Shiihara J, Miyazawa H, Ohta H, Higo M, Nagai Y, Kobayashi K, Saijo Y, Tsuchida M, Nakayama M, Hagiwara K.
- Journal Title
  
  PLoS One
  
  Volume: 12(4) Issue: 4 Pages: 1-14
- DOI
  10.1371/journal.pone.0176525
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09562, KAKENHI-PROJECT-15K10235, KAKENHI-PROJECT-16K15461
[Presentation] 小細胞肺癌治療が抗腫瘍免疫に及ぼす影響2019
- Author(s)
  西原冬実、四宮俊、橋本康佑、三浦雄、塩野文子、山口央、毛利篤人、村山芳武、解良恭一、小林国彦、各務博
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09665
[Presentation] Phase II study to evaluate the peripheral blood mononuclear cell biomarker for nivolumab efficacy on previously treated non-small cell lung cancer subjects2019
- Author(s)
  Yosuke Kawashima, Ou Yamaguchi, Kozuki Toshiyuki, Naoki Furuya, Futoshi Kurimoto, Takae Okuno, Tadaaki Yamada, Kenichiro Komiyama, Ko Ryo, Yoshiaki Nagai, Nobuhisa Ishikawa, Toshiyuki Harada, Kana Watanabe, Seike Masahiro, Kenichi Yoshimura, Kunihiko Kobayashi, Hiroshi Kagamu
- Organizer
  ESMO
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04184
[Presentation] Effector CD4+ T-cell induction by thoracic radiotherapy for NSCLC patients2019
- Author(s)
  Yu Miura, Koko Kodaira, Megumi Kenmochi, Tomoko Yamashiro, Ou Yamaguchi, Ayako Shiono, Atsuhito Mouri, Fuyumi Nishihara, Shun Shinomiya, Kosuke Hashimoto, Yoshitake Murayama, Kunihiko Kobayashi, Kyoichi Kaira, and Hiroshi Kagamu
- Organizer
  ESMO
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04184
[Presentation] CD4+ T-cell immunity predicted long-surviving NSCLC patients after PD-1 blockade therapy2019
- Author(s)
  Kyoichi Kaira, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Fuyumi Nishihara, Yu Miura, Shun Shinomiya, Kosuke Hashimoto, Yoshitake Murayama, Shigehiko Kitano, Kunihiko Kobayashi, and Hiroshi Kagamu
- Organizer
  ASCO
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04184
[Presentation] 小細胞肺癌標準治療が及ぼす免疫学的影響2018
- Author(s)
  西原冬実、山口央、毛利篤人、塩野文子、内田貴裕、橋本康佑、三浦雄、村山芳武、解良恭一、小林国彦、各務博
- Organizer
  日本臨床腫瘍学会
- Data Source
  KAKENHI-PROJECT-17H04184
[Presentation] ニボルマブによるirILDと予後、効果、末梢血CD62Llow CD4+ T細胞との関係2018
- Author(s)
  山口央、毛利篤人、塩野文子、内田貴裕、橋本康佑、西原冬実、三浦雄、村山芳武、解良恭一、小林国彦、各務博
- Organizer
  日本肺癌学会
- Data Source
  KAKENHI-PROJECT-17H04184

1. INOUE Kenich (70443059)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
2. YAMAOKA Kazue (50091038)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. KAGAMU HIROSHI (30418686)

# of Collaborated Projects: 2 results

# of Collaborated Products: 17 results
4. 松田彩子 (30618997)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
5. OGHOSHI Kyoji (30112775)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. Kubota Kaoru (70501857)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. Nishihara Fuyumi (60406478)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
8. 仁井谷久暢 (10076945)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 倉根修二 (70186493)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 渋谷昌彦 (50142534)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 青山昭徳 (60089688)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 矢野侃 (00133447)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 石田博徳 (70274587)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 萩原弘一 (00240705)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 毛利篤人

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kobayashi Kunihiko 小林 国彦

小林 国彦 コバヤシ クニヒコ

KOBAYASHI Kunihiko 小林 国彦

Research Projects

Research Products

Co-Researchers

長期治療をともなう乳がん患者の治療アドヒアランスに及ぼす要因と治療継続への影響

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Study on a type of chemotherapy regimen that induces immune status into response pattern for anti-PD-1 antibody in small lung cancer patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of Breakthrough Immune Checkpoint Inhibitory Therapy Using Novel Immunological Biomarkers

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of the QOL monitoring of the cancer patient

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Outcome evaluation in health science : Cross-cultural equivalence in the quality of life scoring procedure

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

延命効果向上を目指した化学療法と養子免疫療法の適切な併用条件の確立に関する研究

Principal Investigator

Project Period (FY)

Research Category

Research Institution

[Journal Article] Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] CD4(+) T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] D4(+) T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy.2020

Author(s)

Journal Title

Data Source

[Journal Article] Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab2019

Author(s)

Journal Title

DOI

Data Source

Kobayashi Kunihiko 小林国彦

小林国彦コバヤシクニヒコ

KOBAYASHI Kunihiko 小林国彦